Combination Therapy with Venetoclax for Patients With Chronic Lymphocytic Leukemia

In May 2019, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). According to Milos Miljković, M.D., who studies Chronic Lymphocytic Leukemia in NCI’s Center for Cancer Research, “This is the 2’nd chemotherapy-free […]

Indian Pharma Network helps in accessing new products in India. These products are launched and approved recently in USA or Europe but yet to be approved in India. We help in accessing these new launches through named patient import.

Quick Links
About Us

Indian Pharma Network facilitates patients connecting with genuine pharmaceutical suppliers, wholesalers and dealers.

Indian Pharma Network.
info@indianpharmanetwork.in
Corporate Office
Indian Pharma Network.
905 – 9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
info@indianpharmanetwork.in

  • +91 9310090915